A detailed history of Founders Financial Alliance, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Founders Financial Alliance, LLC holds 1,995 shares of NVO stock, worth $174,303. This represents 0.07% of its overall portfolio holdings.

Number of Shares
1,995
Previous 1,994 0.05%
Holding current value
$174,303
Previous $284,000 16.55%
% of portfolio
0.07%
Previous 0.09%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$119.07 - $145.42 $119 - $145
1 Added 0.05%
1,995 $237,000
Q2 2024

Aug 23, 2024

BUY
$122.71 - $146.91 $6,626 - $7,933
54 Added 2.78%
1,994 $284,000
Q1 2024

May 14, 2024

BUY
$102.11 - $135.92 $198,093 - $263,684
1,940 New
1,940 $249,000
Q4 2020

Feb 04, 2021

SELL
$63.89 - $73.8 $10,030 - $11,586
-157 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$63.69 - $70.22 $9,999 - $11,024
157 New
157 $11,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Founders Financial Alliance, LLC Portfolio

Follow Founders Financial Alliance, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Founders Financial Alliance, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Founders Financial Alliance, LLC with notifications on news.